- Supports emotional balance and mood*
- Supports joint comfort and mobility*
- Supports natural inflammatory response*
- Supports cognitive function and clarity*
- Supports natural detoxification processes*
- Supports daily energy and vitality*
- Enteric-coated 200 mg SAM-e*
- Third-Party Tested for Purity & Quality*
Product Details
LifeSource Vitamins SAM-e 200 mg — Enteric-Coated Tablets, 60 Count — Supports Mood & Joint Health*
Clinically studied S-adenosyl-L-methionine (SAM-e) to support mood, joint comfort, and liver health. Enteric-coated for stability and absorption. Produced in FDA-registered, GMP-certified facilities and 3rd-party tested for identity, potency & purity.*
Explore the clinical research, ingredient science, and global evidence supporting this product below.
✓ Improves depressive symptoms (vs. placebo) — Inpatients with major depressive disorder taking oral SAM-e showed significant symptom improvement vs. placebo (randomized, double-blind). NIH/PubMed — Kagan, 1990
✓ Comparable to a prescription TCA with better tolerability — In two multicenter randomized double-blind trials, SAM-e matched imipramine’s antidepressant efficacy with fewer adverse events. NIH/PubMed — Delle Chiaie, 2002
✓ Reduces knee osteoarthritis pain & improves function — Randomized double-blind trial (IV then oral SAM-e) showed clinically meaningful pain reduction vs. placebo in knee OA. NIH/PubMed — Bradley, 1994
✓ Improves pruritus in intrahepatic cholestasis of pregnancy — Randomized study found pruritus improvement with SAM-e; UDCA and combination therapy improved biochemistries more. NIH/PubMed — Binder, 2006
✓ Depression (evidence synthesis) — Systematic reviews/meta-analyses of RCTs report overall antidepressant effects of SAM-e vs. placebo or parity with SSRIs/TCAs; results vary and more large trials are needed. NIH/PubMed — Limveeraprajak, 2024
✓ Osteoarthritis (evidence synthesis) — Cochrane review summary: SAM-e may improve pain/function in hip/knee OA; effect sizes modest and heterogeneous. NIH/PMC — Rutjes, 2009
✓ Liver disease (mixed findings) — Reviews/meta-analyses show biochemical improvements in some cholestatic conditions; benefit vs. UDCA often smaller. NIH/PLOS ONE — Guo, 2015
✓ Massachusetts General Hospital / Harvard — Placebo-controlled trials comparing SAM-e with escitalopram/placebo in MDD. NIH/PMC — Mischoulon, 2014
✓ Multicenter European programs — Double-blind trials found SAM-e comparable to imipramine with fewer adverse events. NIH/PubMed — Delle Chiaie, 2002
- S-Adenosyl-L-Methionine (SAM-e) — Methyl donor studied in human trials for mood, joint, and cholestatic liver outcomes (NIH/PubMed — Kagan, 1990).
- Supports a healthy, positive mood*
- Helps maintain joint comfort in everyday activity*
- Supports liver health in select settings*
- 3rd-party lab tested for purity & potency
Take 1 tablet daily on an empty stomach, or as directed by your healthcare professional. Do not exceed suggested use. If pregnant, nursing, taking medications, or have a medical condition (including bipolar disorder), consult your physician. Keep out of reach of children.*
• Serving Size — 1 enteric-coated tablet
• Amount Per Serving — SAM-e 200 mg (from 400 mg s-adenosyl-L-methionine tosyolate)
• Servings Per Container — 60
• Form — Enteric-coated tablets
• Free From — Non-GMO, gluten-free, no artificial colors or preservatives*
• Quality — Third-party tested for identity, potency & purity
Click here to see our 3rd-party testing.
LifeSource Vitamins — Proudly American — Since 1992
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
SAM-e 200 mg enteric-coated tablets — supports mood, joint comfort & liver health; third-party tested. Clinically Studied Ingredients — NIH/PubMed!*